AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,884,000 | +369.1% | 257,855 | +127.5% | 0.01% | +400.0% |
| Q2 2020 | $1,894,000 | +367.7% | 113,365 | +303.4% | 0.00% | – |
| Q1 2020 | $405,000 | -68.8% | 28,100 | -27.5% | 0.00% | -100.0% |
| Q4 2019 | $1,299,000 | +464.8% | 38,783 | +253.6% | 0.00% | – |
| Q3 2019 | $230,000 | -55.8% | 10,967 | -42.5% | 0.00% | -100.0% |
| Q3 2018 | $520,000 | +145.3% | 19,072 | +141.4% | 0.00% | – |
| Q2 2018 | $212,000 | -60.2% | 7,900 | -52.8% | 0.00% | -100.0% |
| Q1 2018 | $533,000 | +111.5% | 16,741 | +68.4% | 0.00% | -50.0% |
| Q3 2015 | $252,000 | – | 9,943 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 1,240,000 | $25,966,000 | 57.34% |
| Foresite Capital Management II, LLC | 2,605,499 | $54,559,000 | 11.53% |
| Foresite Capital Management III, LLC | 611,893 | $12,813,000 | 4.89% |
| Palo Alto Investors LP | 3,471,740 | $72,698,000 | 4.84% |
| SANDERS MORRIS HARRIS LLC | 486,906 | $10,196,000 | 2.47% |
| Eventide Asset Management | 3,084,000 | $64,579,000 | 2.13% |
| Sofinnova Investments, Inc. | 346,770 | $7,261,000 | 0.66% |
| EMERALD ADVISERS, LLC | 610,511 | $12,784,000 | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 752,358 | $15,754,000 | 0.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 587,464 | $12,301,000 | 0.54% |